☆ 4.7 Letter

Correspondence on 'Immunogenicity and safety of anti-SARS-Cov-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'

ANNALS OF THE RHEUMATIC DISEASES (2021)

期刊

ANNALS OF THE RHEUMATIC DISEASES

卷 80, 期 10, 页码 -

出版社

BMJ PUBLISHING GROUP

DOI: 10.1136/annrheumdis-2021-220496

关键词

-

类别

Rheumatology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Rheumatology

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

Ulf M. Geisen, Dennis K. Berner, Florian Tran, Melike Suembuel, Lena Vullriede, Maria Ciripoi, Hayley M. Reid, Annika Schaffarzyk, Ann C. Longardt, Jeanette Franzenburg, Paula Hoff, Jan H. Schirmer, Rainald Zeuner, Anette Friedrichs, Andrea Steinbach, Christine Knies, Robert D. H. Markewitz, Peter J. Morrison, Sascha Gerdes, Stefan Schreiber, Bimba F. Hoyer

Summary: In this study, the efficacy and safety of anti-SARS-CoV-2 mRNA vaccines in immunosuppressed patients were compared with healthy controls. The results showed that all study participants developed antibodies, with lower IgG titres in patients compared to controls. Side effects were minimal and no disease flares were observed, demonstrating the efficiency and safety of mRNA vaccines in this cohort despite its small size.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Article Immunology

Influence of SARS-CoV-2 mRNA Vaccine Booster among Cancer Patients on Active Treatment Previously Immunized with Inactivated versus mRNA Vaccines: A Prospective Cohort Study

Sebastian Mondaca, Benjamin Walbaum, Nicole Le Corre, Marcela Ferres, Alejandro Valdes, Constanza Martinez-Valdebenito, Cinthya Ruiz-Tagle, Patricia Macanas-Pirard, Patricio Ross, Betzabe Cisternas, Patricia Perez, Olivia Cabrera, Valentina Cerda, Ivana Ormazabal, Aldo Barrera, Maria E. Prado, Maria I. Venegas, Silvia Palma, Richard Broekhuizen, Alexis M. Kalergis, Susan M. Bueno, Manuel A. Espinoza, M. Elvira Balcells, Bruno Nervi

Summary: Cancer patients receiving chemotherapy treatment have a lower immune response to SARS-CoV-2 vaccines. Our study demonstrated that booster vaccines elicit strong humoral and cellular responses among cancer patients receiving chemotherapy, regardless of the type of vaccine used as a priming dose. The homologous vaccine regimen was associated with higher neutralizing antibody positivity and total antibody levels.

VACCINES (2023)

添加到收藏夹

Article Immunology

Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study

Theerada Assawasaksakul, Tanat Lertussavavivat, Seelwan Sathitratanacheewin, Nont Oudomying, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Yingyos Avihingsanon, Nawaporn Assawasaksakul, Supranee Buranapraditkun, Wonngarm Kittanamongkolchai

Summary: This study compared the immunogenicity and safety of three COVID-19 vaccine regimens in patients with SLE and RA. The study found that adenovirus-vectored and adenovirus-vectored/mRNA vaccines elicited a stronger immune response and may be more suitable for patients receiving immunosuppressive therapy.

VACCINES (2022)

添加到收藏夹

Article Virology

Immunogenicity and safety of the BNT162b2 COVID-19 mRNA vaccine in PLWH: A monocentric study in Bari, Italy

Eugenio Milano, Aurelia Ricciardi, Raffaella Casciaro, Elisabetta Pallara, Elda De Vita, Davide F. Bavaro, Angela Maria Vittoria Larocca, Pasquale Stefanizzi, Silvio Tafuri, Annalisa Saracino

Summary: This study evaluated the immunogenicity and safety of the BNT162b2 vaccine in people living with HIV infection. The results showed that the vaccine regimen was immunogenic and well-tolerated in this population, with the majority of patients developing positive titer antibodies. No severe adverse events were reported.

JOURNAL OF MEDICAL VIROLOGY (2022)

添加到收藏夹

Article Hematology

Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study

J. Erika Haydu, Jenny S. Maron, Robert A. Redd, Kathleen M. E. Gallagher, Stephanie Fischinger, Jeffrey A. Barnes, Ephraim P. Hochberg, P. Connor Johnson, R. W. Takvorian, Katelin Katsis, Daneal Portman, Jade Ruiters, Sidney Sechio, Mary Devlin, Connor Regan, Kimberly G. Blumenthal, Aleena Banerji, Allen D. Judd, Krista J. Scorsune, Brianne M. McGree, Maryanne M. Sherburne, Julia M. Lynch, James I. Weitzman, Matthew Lei, Camille N. Kotton, Anand S. Dighe, Marcela V. Maus, Galit Alter, Jeremy S. Abramson, Jacob D. Soumerai

Summary: This prospective study demonstrates that SARS-CoV-2 vaccination induces functional T-cell and antibody responses in patients with CLL. The serologic response to the vaccine is more common in treatment-naive patients. Most patients had functional spike-specific T-cell responses in interferon-gamma release assays.

BLOOD ADVANCES (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Immunogenicity and Safety of Three Types of SARS-CoV-2 Vaccines in Adult Patients with Immune-Mediated Inflammatory Diseases: A Longitudinal Cohort Study

Ni Tien, Yu-Chang Chang, Po-Ku Chen, Hui-Ju Lin, Shih-Hsin Chang, Joung-Liang Lan, Po-Ren Hsueh, Ching-Kun Chang, Der-Yuan Chen

Summary: This study evaluated the immunogenicity and safety of three types of vaccines in patients with immune-mediated inflammatory diseases (IMID) and healthcare workers (HCWs). The study found that mRNA-1273 or BNT162b2 vaccines had higher immunogenicity compared to the AZD1222 vaccine. Immunogenicity was enhanced after the second dose of any vaccine type in all IMID patients. Patients receiving abatacept/rituximab therapy had lower immunogenicity compared to those receiving other DMARDs. All three SARS-CoV-2 vaccines showed acceptable safety profiles, with injection site reactions being the common adverse events.

BIOMEDICINES (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot Study

Francesca La Gualana, Francesca Maiorca, Ramona Marrapodi, Francesca Villani, Marzia Miglionico, Stefano Angelo Santini, Fabio Pulcinelli, Laura Gragnani, Silvia Piconese, Massimo Fiorilli, Stefania Basili, Milvia Casato, Lucia Stefanini, Marcella Visentini

Summary: New-generation mRNA and adenovirus vectored vaccines show immunogenic, inflammatory, and immunomodulatory properties against SARS-CoV-2 spike protein. A noninflammatory tolerogenic mRNA vaccine (MOGm1 psi) has been developed to induce expansion of antigen-specific regulatory T (Treg) cells. The BNT162b2 mRNA vaccine and MOGm1 psi have similar effects on Treg cells, but differ in lipid carrier composition. More studies are needed to confirm the capacity of BNT162b2 and MOGm1 psi in promoting Treg cell expansion.

BIOMEDICINES (2023)

添加到收藏夹

Review Immunology

An Update on mRNA-Based Viral Vaccines

Subbiah Jeeva, Ki-Hye Kim, Chong Hyun Shin, Bao-Zhong Wang, Sang-Moo Kang

Summary: The review discusses the emergence of mRNA vaccines for other infectious diseases following the success of COVID-19 vaccines, detailing the structural elements needed for designing mRNA vaccine constructs and providing updates on mRNA vaccines for SARS-CoV-2, influenza virus, and other pathogens. Unique features of mRNA vaccine platforms and future perspectives are also explored.

VACCINES (2021)

添加到收藏夹

Article Immunology

Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital

Vidya Arankalle, Archana Kulkarni-Munje, Ruta Kulkarni, Sonali Palkar, Rahul Patil, Jitendra Oswal, Sanjay Lalwani, Akhilesh Chandra Mishra

Summary: This study assessed the immune response of healthcare workers to COVISHIELD and COVAXIN vaccines. The results showed that COVISHIELD generated higher neutralizing antibody titers while COVAXIN exhibited a stronger T-cell response. However, after 6 months, there was a decrease in neutralizing antibody titers, emphasizing the need for early booster immunization.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis

Angela Choi, Matthew Koch, Kai Wu, Laurence Chu, LingZhi Ma, Anna Hill, Naveen Nunna, Wenmei Huang, Judy Oestreicher, Tonya Colpitts, Hamilton Bennett, Holly Legault, Yamuna Paila, Biliana Nestorova, Baoyu Ding, David Montefiori, Rolando Pajon, Jacqueline M. Miller, Brett Leav, Andrea Carfi, Roderick McPhee, Darin K. Edwards

Summary: The study demonstrates that both the mRNA-1273 COVID-19 vaccine and its variant-modified booster doses are safe and effective in improving neutralizing antibody titers against various virus variants.

NATURE MEDICINE (2021)

添加到收藏夹

Review Medicine, Research & Experimental

SARS- CoV-2 vaccines: a triumph of science and collaboration

Jonathan L. Golob, Njira Lugogo, Adam S. Lauring, Anna S. Lok

Summary: Multiple vaccines targeting the SARS-CoV-2 surface glycoprotein have shown high efficacy in preventing symptomatic COVID-19, with success attributed to open science collaboration, harmonized clinical trials, and the altruism of study participants. Challenges remain in manufacturing and distributing vaccines, with a focus now shifting towards ensuring equitable global vaccination against COVID-19.

JCI INSIGHT (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice

Baoling Ying, Suzanne M. Scheaffer, Bradley Whitener, Chieh-Yu Liang, Oleksandr Dmytrenko, Samantha Mackin, Kai Wu, Diana Lee, Laura E. Avena, Zhenlu Chong, James Brett Case, LingZhi Ma, Thu T. M. Kim, Caralyn E. Sein, Angela Woods, Daniela Montes Berrueta, Gwo-Yu Chang, Guillaume Stewart-Jones, Isabella Renzi, Yen-Ting Lai, Agata Malinowski, Andrea Carfi, Sayda M. Elbashir, Darin K. Edwards, Larissa B. Thackray, Michael S. Diamond

Summary: The study showed that current vaccination can enhance protection against Omicron infections, but different vaccines have varying efficacy, which requires further investigation.

CELL (2022)

添加到收藏夹

Article Clinical Neurology

Three to four mRNA COVID-19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization

Celine Louapre, Lisa Belin, Stephane Marot, Amandine Hippolyte, Edouard Januel, Michella Ibrahim, Lina Jeantin, Karen Zafilaza, Isabelle Malet, Fanny Charbonnier-Beaupel, Michelle Rosenzwajg, Cathia Soulie, Anne-Genevieve Marcelin, Valerie Pourcher

Summary: This study evaluated the serological response and neutralizing activity of a modified SARS-CoV-2 vaccine regimen in multiple sclerosis (MS) patients. The results showed that after receiving the enhanced vaccination, the antibody response and neutralizing activity improved in patients treated with anti-CD20. However, the neutralizing activity against the Omicron variant remained low.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

添加到收藏夹

Review Immunology

Nanomaterial Delivery Systems for mRNA Vaccines

Michael D. Buschmann, Manuel J. Carrasco, Suman Alishetty, Mikell Paige, Mohamad Gabriel Alameh, Drew Weissman

Summary: This review highlights the recent success of mRNA vaccines in SARS-CoV-2 clinical trials, emphasizing the crucial role of lipid nanoparticles in the delivery systems and providing an analysis of the determinants of lipid nanoparticles' performance in mRNA vaccines.

VACCINES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity

Jillian R. R. Jaycox, Carolina Lucas, Inci Yildirim, Yile Dai, Eric Y. Y. Wang, Valter Monteiro, Sandra Lord, Jeffrey Carlin, Mariko Kita, Jane H. H. Buckner, Shuangge Ma, Melissa Campbell, Albert Ko, Saad Omer, Carrie L. L. Lucas, Cate Speake, Akiko Iwasaki, Aaron M. M. Ring

Summary: mRNA-based vaccines reduce the occurrence and severity of COVID-19, but may have rare adverse effects. This study investigates whether these vaccines can also promote the development of autoantibodies, particularly in autoimmune patients. The researchers found that most individuals generate robust virus-specific antibody responses after vaccination, but autoimmune patients on certain immunosuppression methods have impaired immune responses. The dynamics of autoantibodies are stable in vaccinated patients, unlike COVID-19 patients who exhibit an increased prevalence of new autoantibody reactivities.

NATURE COMMUNICATIONS (2023)

添加到收藏夹

Article Urology & Nephrology

Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry

Elisa Delbarba, Laura Econimo, Chiara Dordoni, Eva Martin, Cinzia Mazza, Gianfranco Savoldi, Federico Alberici, Francesco Scolari, Claudia Izzi

Summary: Causative mutations in the GANAB gene have been described in only 14 families, with 9 diagnosed with late-onset ADPKD and 5 with ADPLD. A new family with late-onset ADPKD due to the p.R839W GANAB variant was reported, previously reported in a severe ADPLD patient requiring liver transplantation.

JOURNAL OF NEPHROLOGY (2022)

添加到收藏夹

Article Rheumatology

Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study

Alessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, Vincent Cottin, Franco Franceschini, Stefano Del Giacco, Franco Schiavon, Thomas Neumann, Giuseppe Lopalco, Pavel Novikov, Chiara Baldini, Carlo Lombardi, Alvise Berti, Federico Alberici, Marco Folci, Simone Negrini, Renato Alberto Sinico, Luca Quartuccio, Claudio Lunardi, Paola Parronchi, Frank Moosig, Georgina Espigol-Frigole, Jan Schroeder, Anna Luise Kernder, Sara Monti, Ettore Silvagni, Claudia Crimi, Francesco Cinetto, Paolo Fraticelli, Dario Roccatello, Angelo Vacca, Aladdin J. Mohammad, Bernhard Hellmich, Maxime Samson, Elena Bargagli, Jan Willem Cohen Tervaert, Camillo Ribi, Davide Fiori, Federica Bello, Filippo Fagni, Luca Moroni, Giuseppe Alvise Ramirez, Mouhamad Nasser, Chiara Marvisi, Paola Toniati, Davide Firinu, Roberto Padoan, Allyson Egan, Benjamin Seeliger, Florenzo Iannone, Carlo Salvarani, David Jayne, Domenico Prisco, Augusto Vaglio, Giacomo Emmi

Summary: Mepolizumab at both 100 mg every 4 weeks and 300 mg every 4 weeks proved effective in treating EGPA, with no significant difference between the two doses. Complete response rates reached 30.4% at 12 months and 35.7% at 24 months, with some patients experiencing exacerbations in asthma and ENT.

ARTHRITIS & RHEUMATOLOGY (2022)

添加到收藏夹

Letter Urology & Nephrology

Hemodialysis techniques and outcomes in patients with COVID-19: The Brescia experience

Federico Alberici, Stefania Affatato, Elisa Delbarba, Mario Gaggiotti, Francesco Scolari

CLINICAL NEPHROLOGY (2022)

添加到收藏夹

Article Urology & Nephrology

SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response

Federico Alberici, Stefania Affatato, Daniele Moratto, Federica Mescia, Elisa Delbarba, Alice Guerini, Martina Tedesco, Peter D. Burbelo, Roberta Zani, Ilaria Castagna, Agnese Gallico, Mattia Tonoli, Margherita Venturini, Aldo M. Roccaro, Mauro Giacomelli, Jeffrey Cohen, Viviana Giustini, Kerry Dobbs, Helen C. Su, Chiara Fiorini, Virginia Quaresima, Fabio Battista Viola, Valerio Vizzardi, Mario Gaggiotti, Nicola Bossini, Paola Gaggia, Raffaele Badolato, Luigi D. Notarangelo, Marco Chiarini, Francesco Scolari

Summary: Dialysis and kidney transplant patients with COVID-19 exhibit immunophenotype abnormalities, with kidney transplant recipients showing more profound alterations of the innate immune system and lower anti-spike antibody response.

JOURNAL OF NEPHROLOGY (2022)

添加到收藏夹

Letter Urology & Nephrology

Lessons From the Clinic: ADPKD Genetic Test Unraveling Severe Phenotype, Intrafamilial Variability, and New, Rare Causing Genotype

Claudia Izzi, Chiara Dordoni, Elisa Delbarba, Cinzia Mazza, Gianfranco Savoldi, Laura Econimo, Roberta Cortinovis, Letizia Zeni, Eva Martin, Federico Alberici, Francesco Scolari

KIDNEY INTERNATIONAL REPORTS (2022)

添加到收藏夹

Review Immunology

Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia

Francesco Scolari, Federico Alberici, Federica Mescia, Elisa Delbarba, Hernando Trujillo, Manuel Praga, Claudio Ponticelli

Summary: Primary Membranous Nephropathy (PMN) is the most common cause of nephrotic syndrome in adults and can lead to end-stage renal disease if left untreated. This review discusses the evidence for different immunosuppressive regimens used for PMN and provides recommendations based on current evidence. The association of PMN with HLA-DQA1 and the presence of autoantibodies support the autoimmune nature of the disease.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Rheumatology

Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study

Manuel Alfredo Podesta, Federica Mescia, Anna Ricchiuto, Rona Smith, Martina Tedesco, Matthias Arnaldo Cassia, Julia Holle, Renato Alberto Sinico, Annette Bruchfeld, Iva Gunnarsson, Sophie Ohlsson, Bo Baslund, Zdenka Hruskova, Vladimir Tesar, Gianmarco Sabiu, Maurizio Gallieni, Maria C. Cid, Augusto Vaglio, Lorraine Harper, Mario Cozzolino, Francesco Scolari, David Jayne, Federico Alberici

Summary: This study aims to assess factors associated with hypogammaglobulinemia in AAV patients treated with rituximab, and the results showed that hypogammaglobulinemia is common in AAV patients treated with rituximab, and lower IgG levels are associated with severe infections. Age and higher glucocorticoid doses increase the risk of hypogammaglobulinemia in these patients.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Pathology

Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies

Greta Bindi, Andrew Smith, Glenda Oliveira, Albino Eccher, Simona Vatrano, Federico Alberici, Giorgio Cazzaniga, Stefania Galimberti, Giulia Capitoli, Fulvio Magni, Fabio Pagni, Vincenzo L'Imperio

Summary: In this study, a new in situ proteomic technique called matrix-assisted laser desorption/ionisation mass spectrometry imaging (MALDI-MSI) was investigated as an alternative to conventional laser capture microdissection MS for the characterisation of amyloids. The results showed that MALDI-MSI correctly identified and typed known amyloid types and identified amyloidosis in challenging cases.

JOURNAL OF CLINICAL PATHOLOGY (2023)

添加到收藏夹

Editorial Material Rheumatology

The paradigm shift in ANCA-associated vasculitis: prime time for the complement targeting

Luca Quartuccio, Elena Treppo, Federico Alberici

RHEUMATOLOGY (2023)

添加到收藏夹

Review Immunology

Unmet needs in ANCA-associated vasculitis: Physicians' and patients' perspectives

Luca Quartuccio, Elena Treppo, Livio Urso, Giulia Del Frate, Federica Mescia, Federico Alberici, Augusto Vaglio, Giacomo Emmi

Summary: In recent years, there has been significant progress in clinical research and treatments for ANCA-associated vasculitis. However, there are still unanswered questions and unmet needs regarding AAV patients, such as predicting relapse and improving quality of life. Identifying predictors of relapse can optimize therapies and reduce side effects, while recognizing the long-term consequences of the disease and its treatment is crucial. This review aims to highlight achievements, challenges, and the perspectives of physicians and patients.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Article Urology & Nephrology

The place of cyclical therapy for the treatment of membranous nephropathy in the era of rituximab

Federico Alberici, Federica Mescia, Francesco Scolari

Summary: Primary membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults and is often caused by autoantibodies against PLA2R. Immunosuppression therapy, such as cyclical therapy, is effective in inducing remission and reducing the risk of end-stage renal disease. Rituximab has emerged as a key player in MN management, with comparable effectiveness and likely better safety compared to the cyclical regimen. However, there are still uncertainties, especially for patients resistant to Rituximab or with severe disease. This article aims to illustrate the role of cyclical therapy in the era of Rituximab.

CLINICAL KIDNEY JOURNAL (2023)

添加到收藏夹

Article Allergy

Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group

Marco Caminati, Angelo Fassio, Federico Alberici, Chiara Baldini, Federica Bello, Paolo Cameli, Edoardo Conticini, Vincent Cottin, Claudia Crimi, Lorenzo Dagna, Paolo Delvino, Alban Deroux, Emine Duran, Georgina Espigol-Frigole, Omer Karadag, Matteo Maule, Sergey Moiseev, Sara Monti, Luca Moroni, Roberto Padoan, Gregory Pugnet, Camille Taille, Paola Toniati, Augusto Vaglio, Giacomo Emmi

ALLERGY (2023)

添加到收藏夹

Article Transplantation

Sustained post-rituximab B-cell depletion is common in ANCA-associated vasculitis and is affected by sex and renal function

Federica Mescia, Chiara Salviani, Mattia Tonoli, Stefania Affatato, Daniele Moratto, Martina Tedesco, Alice Guerini, Alessia Gemmo, Marta Camoni, Elisa Delbarba, Roberto Zubani, Emirena Garrafa, Marco Chiarini, Gina Gregorini, Francesco Scolari, Federico Alberici

Summary: There is still uncertainty about the optimal dosing of rituximab in AAV patients. This study found that a subset of patients experienced sustained B-cell depletion after rituximab treatment, which was associated with reduced risk of flare and increased risk of serious infection in the long term. Preserved renal function and female sex were associated with faster B-cell repopulation.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

添加到收藏夹

Meeting Abstract Transplantation

RENAL FUNCTION IS A MAJOR DETERMINANT OF B-CELL REPOPULATION FOLLOWING RITUXIMAB INDUCTION IN ANCA-ASSOCIATED VASCULITIS

Federica Mescia, Chiara Salviani, Stefania Affatato, Mattia Tonoli, Alice Guerini, Martina Tedesco, Daniele Moratto, Alessandra Gina Gregorini, Marco Chiarini, Francesco Scolari, Federico Alberici

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.